Pliant Therapeutics Statistics
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.99-0.04 (-3.88%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pliant Therapeutics by the numbers
Pliant Therapeutics has a market capitalization of $61.3 million based on 61.92M shares outstanding. With trailing EPS of $-1.44, Pliant Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.0% below its 50-day average and 17.0% below its 200-day average.
Average daily trading volume is 488.25K shares, or about $483,363 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PLRX valuation vs. peer median
| Metric | PLRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $61.30M | $60.25M | +2% |
| Avg. volume | 488.25K | 172.83K | +183% |
Peer median across 8 companies: RNXT, ATHE, GOSS, BOLD, APLM, CNTB, XLO, ACET.
Valuation
- Market cap
- $61.30M
- EPS (TTM)
- $-1.44
- Shares outstanding
- 61.92M
Price and trading
- Previous close
- 1.03
- Open
- 1.03
- Day range
- 0.97 – 1.03
- 52-week range
- 0.97 – 1.95
- 52-week change
- -33.11%
- Beta
- —
- Volume
- 756.50K
- Average volume
- 488.25K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 61.30M
- Forward Pe
- -0.77
- Eps
- -1.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.95
- Week52 Low
- 0.97
- Avg Volume
- 488.25K
- Shares Outstanding
- 61.92M
- Ma50
- 1.10
- Ma200
- 1.19
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -49.23%
- Pct From52w Low
- 2.06%